Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeaeisolates from Poland, 2010-2012

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults

(2013) C Bignell et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada

(2013) Vanessa G. Allen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure

(2013) D. A. Lewis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia

(2013) M. Y. Chen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea

(2012) Magnus Unemo et al.   Future Microbiology

Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain

(2012) J. Camara et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone

(2011) Makoto Ohnishi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: NovelpenAMosaic Allele in a Successful International Clone Causes Treatment Failure

(2011) Magnus Unemo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Review and International Recommendation of Methods for Typing Neisseria gonorrhoeae Isolates and Their Implications for Improved Knowledge of Gonococcal Epidemiology, Treatment, and Biology

(2011) M. Unemo et al.   CLINICAL MICROBIOLOGY REVIEWS

Molecular and Structural Analysis of Mosaic Variants of Penicillin-Binding Protein 2 Conferring Decreased Susceptibility to Expanded-Spectrum Cephalosporins inNeisseria gonorrhoeae: Role of Epistatic Mutations

(2010) Joshua Tomberg et al.   BIOCHEMISTRY

Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone

(2010) S.-G. Lee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Gonococcus fights back: is this time a knock out?

(2010) D. A. Lewis   SEXUALLY TRANSMITTED INFECTIONS

Genetics of Chromosomally Mediated Intermediate Resistance to Ceftriaxone and Cefixime in Neisseria gonorrhoeae

(2009) S. Zhao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Real-time PCR and subsequent pyrosequencing for screening ofpenAmosaic alleles and prediction of reduced susceptibility to expanded-spectrum cephalosporins inNeisseria gonorrhoeae 

(2009) Magnus Unemo et al.   APMIS

Meeting the public health challenge of multidrug- and extensively drug-resistantNeisseria gonorrhoeae

(2009) John W Tapsall et al.   Expert Review of Anti-Infective Therapy

Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes

(2009) M. Unemo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods

(2009) J. Tapsall et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone

(2008) Kazuyoshi Osaka et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY